Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
NCT01663103
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Renal Insufficiency, Chronic
Interventions
DRUG:
Rilonacept
DRUG:
Placebo
Sponsor
University of Colorado, Denver